Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Report finds only 35% of Canadian youth get the physical activity recommended for brain health

___

Get­ting kids out­side and active could help with brain health: Par­tic­i­paction report (The Globe and Mail):

The phys­i­cal ben­e­fits of kids lead­ing an active lifestyle, includ­ing bet­ter heart health and a decreased risk of devel­op­ing Type 2 dia­betes, are well known. But a grow­ing body of research sug­gests there are sig­nif­i­cant men­tal ben­e­fits as well, whether it’s low­er­ing stress lev­els or help­ing to treat anx­i­ety and depres­sion. A new report released by Par­tic­i­paction on Tues­day draws atten­tion to this link, Read the rest of this entry »

Here’s a landscape of new ideas harnessing digital tech to upgrade cognitive and mental healthcare

We hope you enjoy this slid­edeck sup­port­ing great for­ward-look­ing ideas shared by pio­neers at Mind­strong Health, Savonix, HealthTech Con­nex and Neu­raMetrix dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 5–7th, 2017).

And please learn more and con­sid­er reserv­ing your spot @ 2018 Sharp­Brains Vir­tu­al Sum­mit: Invest­ing in Brain Health for All (Decem­ber 4–6th, 2018).

Is your brain ready for Monday? Tease your mind with these four optical illusions

___

A great way to learn more about our brains and minds is to look at how we can trick them–that is, to see how we react to brain teasers and visu­al illu­sions.

Below are four fun opti­cal illu­sions that let us learn­ about our visu­al system…ready?

(answers and expla­na­tions at the bot­tom)

___

Read the rest of this entry »

When Healthcare ignores Mental Health: 200 common prescription medications increase depression risk

___

Many Amer­i­cans tak­ing com­mon meds that may cause depres­sion, study finds (CBS News):

More than one-third of U.S. adults are tak­ing pre­scrip­tion med­ica­tions that may lead to depres­sion, new research finds. The study, pub­lished in the Jour­nal of the Amer­i­can Med­ical Asso­ci­a­tion, warns that depres­sion is a poten­tial side effect of more than 200 com­mon­ly pre­scribed med­ica­tions, Read the rest of this entry »

FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

___

Mind­Maze Con­sol­i­dates First-ever FDA Approval for Inpa­tient and Out­pa­tient Neu­rore­ha­bil­i­ta­tion Ther­a­py (press release):

Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States. Togeth­er with Mind­Mo­tion PRO (which received FDA clear­ance in 2017), Mind­Mo­tion GO is the next offer­ing in the company’s con­tin­u­um of care, pro­vid­ing gam­i­fied neu­rore­ha­bil­i­ta­tion ther­a­py. Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.